Avvinity Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series 1
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 5

Avvinity Therapeutics General Information

Description

Operator of an immunotherapy company intended to discover and develop multiple candidate molecules. The company's patent portfolio exemplifies the use of antibodies, antibody fragments, RNA/DNA, Aptamers and small molecules as targeting domains, enabling healhcare institutes to access the technology for the treatment of both solid tumours and leukemia.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • First Floor Thavies Inn House
  • 3-4 Holborn Circus
  • London EC1N 2HA
  • England, United Kingdom

Avvinity Therapeutics Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avvinity Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 01-Aug-2020 $4M 00.000 Completed Generating Revenue
3. Corporate 06-Aug-2019 00000 00.000 0000 Completed Generating Revenue
2. Corporate 03-Aug-2018 $1.84M $1.84M 000.00 Completed Generating Revenue
1. Joint Venture 02-Mar-2016 $110M 00000 Completed Startup
To view Avvinity Therapeutics’s complete valuation and funding history, request access »

Avvinity Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
To view Avvinity Therapeutics’s complete cap table history, request access »

Avvinity Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Nick Staples Ph.D Interim Chief Executive Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Avvinity Therapeutics Board Members (4)

Name Representing Role Since
Jonathan Synett Centauri Therapeutics Board Member 000 0000
Michael Westby Ph.D Centauri Therapeutics Board Member 000 0000
Pauline Stasiak Ph.D LifeArc Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Avvinity Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Government of UK Government Minority 000 0000 000000 0
LifeArc Venture Capital Minority 000 0000 000000 0
NCL Technology Ventures Venture Capital Minority 000 0000 000000 0
Centauri Therapeutics PE-Backed Company Majority 000 0000 000000 0
Horizon Discovery Corporation Minority 000 0000 000000 0
To view Avvinity Therapeutics’s complete investors history, request access »